Advances in Bioscience and Biotechnology
Vol.5 No.5(2014), Paper ID 44476, 9
pages
DOI:10.4236/abb.2014.55049
Evaluation of Quality of Life Related to I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer and Emphasis in Salivary Morbidity: A Follow up Study after Treatment
Lucélia Garcia Corrêa, Sônia Marta Moriguchi, Érica Boldrini, André Lopes de Carvalho, José Humberto Tavares Guerreiro Fregnani, Euclides Timóteo da Rocha
Department of Nuclear Medicine, Barretos Cancer Hospital, Barretos, Brazil
Department of Nuclear Medicine, Medical School, Sao Paulo State University (UNESP), Botucatu, Brazil
Department of Pediatrics, Barretos Cancer Hospital, Barretos, Brazil
Department of Oncological Surgery, Barretos Cancer Hospital, Barretos, Brazil
Department of Oncological Surgery, Barretos Cancer Hospital, Barretos, Brazil
Department of Nuclear Medicine, Barretos Cancer Hospital, Barretos, Brazil
Copyright © 2014 Lucélia Garcia Corrêa, Sônia Marta Moriguchi, Érica Boldrini, André Lopes de Carvalho, José Humberto Tavares Guerreiro Fregnani, Euclides Timóteo da Rocha et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Corrêa, L. , Moriguchi, S. , Boldrini, É. , Carvalho, A. , Guerreiro Fregnani, J. and da Rocha, E. (2014) Evaluation of Quality of Life Related to I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer and Emphasis in Salivary Morbidity: A Follow up Study after Treatment.
Advances in Bioscience and Biotechnology,
5, 409-417. doi:
10.4236/abb.2014.55049.